Analystreport

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target lowered by analysts at Robert W. Baird from $48.00 to $43.00.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report